Moreover, increased glycemic variability may also be related to lower levels of fasting C-peptide, longer diabetic duration in T2D using insulin, older age, obesity, higher TG, lower LDLC and the use of sulfonylurea in T2D without insulin treatment [43]. This evidence concerns the gene INS and Obesity.